These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32271189)

  • 1. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
    Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
    Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired cystic disease-associated renal cell carcinoma: A clinicopathologic study of eight tumors with clinical follow-up.
    Chrabańska M; Ryszawy J; Drozdzowska B
    Indian J Cancer; 2021; 58(4):608-614. PubMed ID: 34975102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

  • 5. [A Case of ACD-Associated RCC with Lymph Node Metastasis and Contralateral Renal Carcinoma after Nephrectomy].
    Makino Y; Tsuchihashi K; Shimizu Y; Kanamaru S; Hashimoto K; Ito N
    Hinyokika Kiyo; 2016 Jul; 62(7):349-53. PubMed ID: 27569352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired cystic disease-associated renal cell carcinoma: a clinicopathological study of seven cases.
    Kuroda N; Naroda T; Tamura M; Yorita K; Kojima F; Murata SI
    Pol J Pathol; 2017; 68(4):306-311. PubMed ID: 29517200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral and Multifocal Acquired Cystic Disease-Associated Renal Cell Carcinomas in Patient With End-Stage Renal Disease Caused by Systemic Lupus Erythematosus.
    Chrabańska M; Jakub R; Bogna D
    Int J Surg Pathol; 2021 Apr; 29(2):198-204. PubMed ID: 32513033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired cystic disease and renal cell carcinoma in hemodialysis patients--A case report on three patients.
    Mijušković M; Milović N; Kovačević B; Jovanović D; Stefanović D; Ignjatović L; Terzić B; Pilčević JT; Petrović M; Pilčević D; Obrencević K; Cerović S
    Vojnosanit Pregl; 2015 Oct; 72(10):932-6. PubMed ID: 26665561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid acquired cystic disease-associated renal cell carcinoma.
    Kuroda N; Tamura M; Taguchi T; Tominaga A; Hes O; Michal M; Ohara M; Hirouchi T; Mizuno K; Hayashi Y; Shuin T; Lee GH
    Histol Histopathol; 2008 Nov; 23(11):1327-31. PubMed ID: 18785115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Duong NX; Le MK; Nguyen TT; Nguyen DD; Vuong HG; Kondo T; Mitsui T
    Clin Genitourin Cancer; 2024 Jun; 22(3):102050. PubMed ID: 38502982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features.
    Kuroda N; Tamura M; Hamaguchi N; Mikami S; Pan CC; Brunelli M; Martignoni G; Hes O; Michal M; Lee GH
    Ann Diagn Pathol; 2011 Dec; 15(6):462-6. PubMed ID: 21036640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paneth-like cells in renal cell carcinomas and in cysts associated with acquired cystic kidney disease: Clinicopathologic analysis, comparative study and description of precursor lesions.
    Kojima F; Alaghehbandan R; Kuroda N; Matsuzaki I; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Iwahashi Y; Warigaya K; Iba A; Hara I; Murata SI; Hes O
    Ann Diagn Pathol; 2021 Apr; 51():151707. PubMed ID: 33516060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features.
    Ahn S; Kwon GY; Cho YM; Jun SY; Choi C; Kim HJ; Park YW; Park WS; Shim JW
    Med Mol Morphol; 2013 Dec; 46(4):225-32. PubMed ID: 23471757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.
    Trpkov K; Hes O; Bonert M; Lopez JI; Bonsib SM; Nesi G; Comperat E; Sibony M; Berney DM; Martinek P; Bulimbasic S; Suster S; Sangoi A; Yilmaz A; Higgins JP; Zhou M; Gill AJ; Przybycin CG; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2016 Jan; 40(1):60-71. PubMed ID: 26414221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tumors in end-stage renal disease: A comprehensive review.
    Tsuzuki T; Iwata H; Murase Y; Takahara T; Ohashi A
    Int J Urol; 2018 Sep; 25(9):780-786. PubMed ID: 30066367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.